blue and white labeled bottle

Study: 2 COVID vaccine doses much more effective than 1 against Delta

Mary Van Beusekom | News Writer | CIDRAP NewsJul 22, 2021Two doses of either Pfizer or AstraZeneca vaccine were 80% effective against the Delta COVID-19 variant. Source: Center for Infectious Disease Research and Policy…

How COVID-19 Spreads-CDC

Global COVID-19 cases rise 12% in past week

Stephanie Soucheray | News Reporter | CIDRAP NewsJul 21, 2021Nations seeing large jumps in cases include Botswana, Vietnam, the US, Indonesia, Malaysia, and the UK. Source: Center for Infectious Disease Research and Policy…

A Year Into Pandemic Federal Officials Move to Better Protect Frontline Workers

A Year Into Pandemic, Federal Officials Move to Better Protect Frontline Workers

Changes would allow N95 sales for industries other than health care and signal an end to the hospital practice of reusing the masks considered essential for worker safety. …

To Extract More Doses per Vial, Vaccinators Put Squeeze on FDA to Relax Vaccine Handling Advice

Arthur Allen March 12, 2021 President Joe Biden has promised enough covid vaccine to immunize every willing adult by June 1. But right now, the gap between supply and demand is so dramatic that vaccinators are discovering ways to suck the final drops out of each vaccine vial — if federal regulators will let them. Pharmacists …

Read more

Feds Focus on Mask Upgrades, COVID-19 Vaccine Sites

Stephanie Soucheray | News Reporter | CIDRAP NewsFeb 10, 2021New CDC data show the fit of face masks may significantly reduce COVID-19 spread. Source: Center for Infectious Disease Research and Policy…

Johnson & Johnson COVID Vaccine Heads to FDA for Emergency Use Decision

Johnson & Johnson COVID Vaccine Heads to FDA for Emergency Use Decision

Johnson & Johnson COVID Vaccine Heads to FDA for Emergency Use Decision | Late yesterday Johnson & Johnson submitted a request for an emergency use authorization (EUA) for its COVID-19 candidate. If the EUA is granted by the Food and Drug Administration (FDA), the vaccine will become the third COVID-19 vaccine approved for use in the United States, and the first that requires only one dose…In light of the request, FDA advisors will meet on Feb 26 to weigh emergency use…

COVID-19 with Cardiac Arrest

COVID-19 with Frailty, Cardiac Arrest May Raise Risk of Death Sharply

COVID-19 with Frailty, Cardiac Arrest May Raise Risk of Death Sharply | Two studies today suggest that COVID-19 patients who are very frail or have a cardiac arrest are two three times more likely to die than those not infected with the virus. | For men with COVID-19, the risk of dying from an out-of-hospital cardiac arrest rose 4.5-fold…

WHO COVID-19 vaccination

WHO Pushes for COVID Vaccine Production Scale-Up, More Sharing

Lisa Schnirring | News Editor | CIDRAP NewsFeb 05, 2021The global number of people vaccinated has now eclipsed the number infected. Source: Center for Infectious Disease Research and Policy…

South African COVID Variant in SC US

South Carolina Detects South African COVID-19 Variant

South Carolina Detects South African COVID-19 Variant Also, an expert warns about hospital oxygen shortages and Novavax reports good phase 3 vaccine data.

Symptoms 4 months after COVID-19

Lingering lung, physical, mental symptoms 4 months after COVID-19

Lingering lung, physical, mental symptoms 4 months after COVID-19| The findings suggest many patients recover very slowly after hospital release | Four months after their release from the hospital, more than half of 238 adult COVID-19 patients in northern Italy still had impaired lung function or mobility issues..